27 January 2022 - A COVID-19 booster shot, targeted specifically at the Omicron variant, is expected to be delivered by September, Moderna has revealed as it advances human trials.
The company said it had developed an Omicron specific vaccine candidate within 63 days of the variant being first detected in South Africa, and it had already been injected into a patient as part of phase 2 clinical trials.